A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management

Background. Hemodynamic-guided therapy using the CardioMEMS™ system has been shown to reduce heart failure hospitalization (HFH) in both clinical trials and real-world settings. However, the CardioMEMS system requires input from multiple independent elements to achieve its effect, and no studies hav...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeffrey S. Tran, Aaron M. Wolfson, Daniel O’Brien, Omid Yousefian, David M. Shavelle
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/7979830
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548263350239232
author Jeffrey S. Tran
Aaron M. Wolfson
Daniel O’Brien
Omid Yousefian
David M. Shavelle
author_facet Jeffrey S. Tran
Aaron M. Wolfson
Daniel O’Brien
Omid Yousefian
David M. Shavelle
author_sort Jeffrey S. Tran
collection DOAJ
description Background. Hemodynamic-guided therapy using the CardioMEMS™ system has been shown to reduce heart failure hospitalization (HFH) in both clinical trials and real-world settings. However, the CardioMEMS system requires input from multiple independent elements to achieve its effect, and no studies have been done to investigate those elements. Consistent patient participation and health care provider participation are two of those key elements, and this study sought to assess how they affect HFHs. Methods. This was a single-center, retrospective cohort study of patients with the CardioMEMS sensor. The primary outcome was the number of HFH days patients experienced in the 1 year following CardioMEMS sensor implant. The primary independent variables were the average number of days between patient transmissions of data and the average number of days between health care provider reviews of those data. Covariates included patient demographics, medical comorbidities, history of HFHs, and initial pressure response to hemodynamic-guided therapy at 28 days after implant. Data were fit to a zero-inflated negative binomial regression. Results. Seventy-eight patients were included in the study. The mean age was 64 ± 15 years, 52 (67%) were male, and 58 (76%) had heart failure with reduced ejection fraction. During the study period, there were 538 cumulative HFH patient-days. Based on the regression model, there was an exponential relationship between HFH days and the mean number of days between patient transmissions (IRR = 1.74, 95% CI: 1.09–2.75, p=0.019). There was also an exponential relationship between HFH days and the mean number of days between health care provider reviews (IRR = 1.03, 95% CI: 1.01–1.05, p=0.013). Conclusions. This single-center study suggests that more frequent patient transmissions and health care provider reviews of the CardioMEMS system are associated with a decreased number of HFH days, but larger multicentered studies are required. Further systems-based analyses of the CardioMEMS system may be a useful approach to guiding effective use of the CardioMEMS device.
format Article
id doaj-art-612edf8f1b6742f7902a0081cfa26ae5
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-612edf8f1b6742f7902a0081cfa26ae52025-02-03T06:15:11ZengWileyCardiology Research and Practice2090-80162090-05972019-01-01201910.1155/2019/79798307979830A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure ManagementJeffrey S. Tran0Aaron M. Wolfson1Daniel O’Brien2Omid Yousefian3David M. Shavelle4Department of Internal Medicine, Keck School of Medicine of USC, Los Angeles 90033, CA, USADivision of Cardiovascular Medicine, University of Southern California, Los Angeles 90033, CA, USAKeck School of Medicine of USC, Los Angeles 90033, CA, USADepartment of Internal Medicine, Keck School of Medicine of USC, Los Angeles 90033, CA, USADivision of Cardiovascular Medicine, University of Southern California, Los Angeles 90033, CA, USABackground. Hemodynamic-guided therapy using the CardioMEMS™ system has been shown to reduce heart failure hospitalization (HFH) in both clinical trials and real-world settings. However, the CardioMEMS system requires input from multiple independent elements to achieve its effect, and no studies have been done to investigate those elements. Consistent patient participation and health care provider participation are two of those key elements, and this study sought to assess how they affect HFHs. Methods. This was a single-center, retrospective cohort study of patients with the CardioMEMS sensor. The primary outcome was the number of HFH days patients experienced in the 1 year following CardioMEMS sensor implant. The primary independent variables were the average number of days between patient transmissions of data and the average number of days between health care provider reviews of those data. Covariates included patient demographics, medical comorbidities, history of HFHs, and initial pressure response to hemodynamic-guided therapy at 28 days after implant. Data were fit to a zero-inflated negative binomial regression. Results. Seventy-eight patients were included in the study. The mean age was 64 ± 15 years, 52 (67%) were male, and 58 (76%) had heart failure with reduced ejection fraction. During the study period, there were 538 cumulative HFH patient-days. Based on the regression model, there was an exponential relationship between HFH days and the mean number of days between patient transmissions (IRR = 1.74, 95% CI: 1.09–2.75, p=0.019). There was also an exponential relationship between HFH days and the mean number of days between health care provider reviews (IRR = 1.03, 95% CI: 1.01–1.05, p=0.013). Conclusions. This single-center study suggests that more frequent patient transmissions and health care provider reviews of the CardioMEMS system are associated with a decreased number of HFH days, but larger multicentered studies are required. Further systems-based analyses of the CardioMEMS system may be a useful approach to guiding effective use of the CardioMEMS device.http://dx.doi.org/10.1155/2019/7979830
spellingShingle Jeffrey S. Tran
Aaron M. Wolfson
Daniel O’Brien
Omid Yousefian
David M. Shavelle
A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
Cardiology Research and Practice
title A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
title_full A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
title_fullStr A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
title_full_unstemmed A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
title_short A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management
title_sort systems based analysis of the cardiomems hf sensor for chronic heart failure management
url http://dx.doi.org/10.1155/2019/7979830
work_keys_str_mv AT jeffreystran asystemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT aaronmwolfson asystemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT danielobrien asystemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT omidyousefian asystemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT davidmshavelle asystemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT jeffreystran systemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT aaronmwolfson systemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT danielobrien systemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT omidyousefian systemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement
AT davidmshavelle systemsbasedanalysisofthecardiomemshfsensorforchronicheartfailuremanagement